There are 6 papers on myotonic dystrophy in aging research: 3 trials in people, 1 in cells, 2 reviews. The newest story, Oct 10, 2026: “Myotonic dystrophy gene changes found in 1 in 1,527 people”.
3 new papers in 30 daysSee all 29 papers on myotonic dystrophy
“Dystrophic myotonic muscles appeared highly sensitive to extracellular potassium”
Segmental progeroid disorder
upin human cells1
Myotonic dystrophy is associated with segmental progeroid disorder in human cells (comparison of clinical and molecular features).
“Our comparison on both clinical and molecular levels argues for qualification of DM as a segmental progeroid disorder.”
Cellscomparison of clinical and molecular features
Myotonic Dystrophy-A Progeroid Disease?
Frontiers in neurology
Progeroid syndromes linked to the nuclear envelope
upin human cells1
Myotonic dystrophy is associated with progeroid syndromes linked to the nuclear envelope in human cells (at the cellular level in primary cell lines).
“This analysis reveals many similarities to progeroid syndromes linked to the nuclear envelope.”
Cellsat the cellular level in primary cell lines
Myotonic Dystrophy-A Progeroid Disease?
Frontiers in neurology
Electrolyte accumulation
upin humans1
Myotonic dystrophy is associated with electrolyte accumulation in humans (potassium chloride challenge).
“favored electrolyte accumulation in dystrophic myotonic muscles”
Human trialpotassium chloride challengethenar eminence muscle
Annals of neurology
Sensitivity to extracellular potassium
upin humans1
Myotonic dystrophy is associated with sensitivity to extracellular potassium in humans (compared with normal muscles).
“Dystrophic myotonic muscles appeared highly sensitive to extracellular potassium”
Human trialcompared with normal musclesthenar eminence muscle
Annals of neurology
1 trial30 people
European Innovation Council€2.5MNational Institute of Arthritis and Musculoskeletal and Skin Diseases$471K
Across 985,026 participants, disease-causing DNA expansions occurred in about 1 in 1,527, compared with earlier disease prevalence estimates of 1 in 3,000–8,000.Across 985,026 participants, disease-causing DNA expansions occurred in about 1 in 1,527, compared with earlier disease prevalence estimates of 1 in 3,000–8,000.